PI3K pathway↑, P-gp↓, ABCG2↓, CD206↓, CD86↑, PGE2, IL-6, CCL1↓, BCL-2↓, Bax↑, drug resistance↓, anti-tumor effect↑. This evidence concerns the gene PIK3CG and neoplasm.